Keros Therapeutics, Inc. (KROS)
11.08
-0.09
(-0.81%)
USD |
NASDAQ |
Sep 11, 16:00
11.10
+0.02
(+0.14%)
After-Hours: 20:00
Keros Therapeutics Price : 11.08 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 11.25 | 11.34 | 11.02 | 11.08 | 143827.0 |
| Sep 10, 2026 | 11.16 | 11.20 | 11.00 | 11.17 | 128792.0 |
| Sep 09, 2026 | 11.48 | 11.82 | 11.21 | 11.31 | 188508.0 |
| Sep 08, 2026 | 11.16 | 11.31 | 10.98 | 11.17 | 73047.00 |
| Sep 04, 2026 | 11.03 | 11.40 | 11.02 | 11.32 | 65636.00 |
| Sep 03, 2026 | 11.27 | 11.32 | 10.92 | 11.11 | 148714.0 |
| Sep 02, 2026 | 11.07 | 11.49 | 10.97 | 11.23 | 97971.00 |
| Sep 01, 2026 | 11.02 | 11.12 | 10.83 | 11.07 | 96241.00 |
| Aug 31, 2026 | 10.93 | 11.20 | 10.76 | 11.08 | 179962.0 |
| Aug 28, 2026 | 11.15 | 11.16 | 10.58 | 11.03 | 328287.0 |
| Aug 27, 2026 | 11.09 | 11.48 | 11.01 | 11.23 | 127576.0 |
| Aug 26, 2026 | 11.66 | 11.66 | 11.08 | 11.12 | 113598.0 |
| Aug 25, 2026 | 10.83 | 11.71 | 10.83 | 11.68 | 200323.0 |
| Aug 24, 2026 | 11.12 | 11.12 | 10.72 | 10.78 | 217076.0 |
| Aug 21, 2026 | 10.96 | 11.09 | 10.80 | 11.03 | 157507.0 |
| Aug 20, 2026 | 11.09 | 11.10 | 10.55 | 10.95 | 203072.0 |
| Aug 19, 2026 | 10.63 | 11.17 | 10.63 | 11.10 | 152155.0 |
| Aug 18, 2026 | 10.38 | 10.67 | 10.12 | 10.61 | 256150.0 |
| Aug 17, 2026 | 10.05 | 10.51 | 10.00 | 10.48 | 221514.0 |
| Aug 14, 2026 | 10.59 | 10.59 | 10.02 | 10.10 | 315284.0 |
| Aug 13, 2026 | 11.28 | 11.43 | 10.64 | 10.66 | 239468.0 |
| Aug 12, 2026 | 10.69 | 11.23 | 10.55 | 11.20 | 159710.0 |
| Aug 11, 2026 | 10.63 | 10.73 | 10.55 | 10.64 | 137923.0 |
| Aug 10, 2026 | 11.15 | 11.18 | 10.54 | 10.69 | 170834.0 |
| Aug 07, 2026 | 10.74 | 11.26 | 10.58 | 11.15 | 319630.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 121.47 |
| Viking Therapeutics, Inc. | 31.98 |
| Nurix Therapeutics, Inc. | 25.10 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
Price Related Metrics
| PS Ratio | 19.79 |
| Price to Book Value | 0.8375 |
| Earnings Yield | -33.39% |
| Market Cap | 219.69M |